195 related articles for article (PubMed ID: 9038617)
1. Cisplatin combined with the new cisplatin-procaine complex DPR: in vitro and in vivo studies.
Viale M; Vannozzi MO; Merlo F; Cafaggi S; Parodi B; Esposito M
Eur J Cancer; 1996 Dec; 32A(13):2327-33. PubMed ID: 9038617
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity and cellular accumulation of a new cis-diammineplatinum (II) complex containing procaine in murine L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II).
Viale M; Cafaggi S; Parodi B; Esposito M
Cancer Chemother Pharmacol; 1995; 35(5):371-6. PubMed ID: 7850917
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor activity of a new cis-diammineplatinum (II) complex containing procaine hydrochloride.
Cafaggi S; Esposito M; Parodi B; Vannozzi MO; Viale M; Pellecchia C; Fulco RA; Merlo F; Zicca A; Cadoni A
Anticancer Res; 1992; 12(6B):2285-92. PubMed ID: 1295476
[TBL] [Abstract][Full Text] [Related]
4. Combination of cisplatin-procaine complex DPR with anticancer drugs increases cytotoxicity against ovarian cancer cell lines.
Viale M; Pastrone I; Pellecchia C; Vannozzi MO; Cafaggi S; Esposito M
Anticancer Drugs; 1998 Jun; 9(5):457-63. PubMed ID: 9660544
[TBL] [Abstract][Full Text] [Related]
5. Improved therapeutic index of cisplatin by procaine hydrochloride.
Esposito M; Fulco RA; Collecchi P; Zicca A; Cadoni A; Merlo F; Rosso R; Sobrero A
J Natl Cancer Inst; 1990 Apr; 82(8):677-84. PubMed ID: 2319610
[TBL] [Abstract][Full Text] [Related]
6. Modifications of cell-cycle induced by dpr, a new platinum-triamine complex containing procaine.
Viale M; Melioli G; Pasquetti W; Meta M; Cafaggi S; Esposito N
Int J Oncol; 1994 May; 4(5):1047-51. PubMed ID: 21567018
[TBL] [Abstract][Full Text] [Related]
7. Effect of the cisplatin-procaine complex DPR in combination with several anticancer agents on murine P388 leukemic cells in vitro and in vivo.
Pastrone I; Viale M; Cafaggi S; Mariggiò MA; Parodi A; Esposito M
Invest New Drugs; 1998-1999; 16(4):297-302. PubMed ID: 10426661
[TBL] [Abstract][Full Text] [Related]
8. Transplacental passage of Pt after treatment with the new triamine complex cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N4]-chloride platinum (II) monohydrochloride monohydrate.
Ognio E; Chiavarina B; Caviglioli G; Lapide M; Viale M
Arch Toxicol; 2004 Oct; 78(10):584-8. PubMed ID: 15150682
[TBL] [Abstract][Full Text] [Related]
9. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
[TBL] [Abstract][Full Text] [Related]
10. Effect of thymidine on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II).
Grossie VB; Valdivieso M; Drewinko B; Loo TL
Cancer Chemother Pharmacol; 1984; 13(1):27-30. PubMed ID: 6539657
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic synergism of tiazofurin and selected antitumor drugs against sensitive and resistant P388 leukemia in mice.
Harrison SD; O'Dwyer PJ; Trader MW
Cancer Res; 1986 Jul; 46(7):3396-400. PubMed ID: 3708573
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
Elliott WL; Roberts BJ; Howard CT; Leopold WR
Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cell growth, induction of apoptosis and mechanism of action of the novel platinum compound cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N(4)]-chloride platinum (II) monohydrochloride monohydrate.
Mariggiò MA; Cafaggi S; Ottone M; Parodi B; Vannozzi MO; Mandys V; Viale M
Invest New Drugs; 2004 Jan; 22(1):3-16. PubMed ID: 14707490
[TBL] [Abstract][Full Text] [Related]
14. Preclinical in vitro evaluation of hematotoxicity of the cisplatin-procaine complex DPR.
Viale M; Minetti S; Ottone M; Lerza R; Parodi B; Pannacciulli I
Anticancer Drugs; 2003 Feb; 14(2):163-6. PubMed ID: 12569303
[TBL] [Abstract][Full Text] [Related]
15. Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline.
Coluccia M; Sava G; Loseto F; Nassi A; Boccarelli A; Giordano D; Alessio E; Mestroni G
Eur J Cancer; 1993; 29A(13):1873-9. PubMed ID: 8260245
[TBL] [Abstract][Full Text] [Related]
16. Para-aminobenzoic acid suppression of cis-diamminedichloroplatinum(II) nephrotoxicity.
Esposito M; Vannozzi MO; Viale M; Fulco RA; Collecchi P; Merlo F; De Cian F; Zicca A; Cadoni A; Poirier MC
Carcinogenesis; 1993 Dec; 14(12):2595-9. PubMed ID: 8269632
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy of early and advanced murine P388 leukaemia with bouvardin, cis-diamminedichloroplatinum and vincristine.
Adwankar MK; Khandalekar DD; Chitnis MP
Oncology; 1984; 41(5):370-3. PubMed ID: 6540853
[TBL] [Abstract][Full Text] [Related]
18. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST
Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897
[TBL] [Abstract][Full Text] [Related]
19. The role of drug sequence in therapeutic selectivity of the combination of 5-fluorouracil and cis-platin.
Palmeri S; Trave F; Russello O; Rustum YM
Sel Cancer Ther; 1989; 5(4):169-77. PubMed ID: 2623382
[TBL] [Abstract][Full Text] [Related]
20. Effect of the antiarrhythmic drug procainamide on the toxicity and antitumor activity of cis-diamminedichloroplatinum(II).
Esposito M; Viale M; Vannozzi MO; Zicca A; Cadoni A; Merlo F; Gogioso L
Toxicol Appl Pharmacol; 1996 Oct; 140(2):370-7. PubMed ID: 8887454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
